Rankings / Metabolic Health

Bempedoic acid

Metabolic Health · ACL inhibitor

Also known as: Nexletol

Tier B-

statinprescription
5.9 / 10
Tier B-
Ev 7 Bn 5 Sf 5

Bottom line

Read Off Label grades Bempedoic acid as B- (5.9/10) based on moderate-strong evidence, moderate benefit magnitude, and a med-risk safety profile.

CLEAR Outcomes 2023 finally gave statin-intolerant patients a non-statin oral with CV outcome data.

Typical use: 180 mg PO daily — Rx.

What this is

CLEAR Outcomes 2023 finally gave statin-intolerant patients a non-statin oral with CV outcome data. Gout flares are a real side effect — screen for baseline uric acid. Expensive relative to ezetimibe with similar LDL reduction.

Mechanism

ATP-citrate lyase inhibitor; blocks cholesterol synthesis upstream of HMG-CoA reductase; prodrug activated only in liver (bypasses muscle → less myalgia); ~20% LDL reduction monotherapy; CLEAR Outcomes trial showed CV benefit

Dose & route

180 mg PO daily

Common questions

Does Bempedoic acid work?
Read Off Label rates the evidence for Bempedoic acid as Moderate-Strong and the benefit magnitude as moderate, producing an overall grade of B- (5.9/10). CLEAR Outcomes 2023 finally gave statin-intolerant patients a non-statin oral with CV outcome data.
Is Bempedoic acid safe?
Bempedoic acid has a med risk profile in published human data. Legal status: Rx (Nexletol; combo with ezetimibe = Nexlizet). This is not medical advice — see the disclaimer.
What is the typical dose for Bempedoic acid?
180 mg PO daily
How does Bempedoic acid work?
ATP-citrate lyase inhibitor; blocks cholesterol synthesis upstream of HMG-CoA reductase; prodrug activated only in liver (bypasses muscle → less myalgia); ~20% LDL reduction monotherapy; CLEAR Outcomes trial showed CV benefit

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.